Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is BioNTech Stock a Buy Now?: https://g.foolcdn.com/editorial/images/751618/doctor-vaccinating-a-patient.jpg
Is BioNTech Stock a Buy Now?

BioNTech (NASDAQ: BNTX) is the lesser-known member of the pair -- which also includes Pfizer -- that developed and marketed Comirnaty, one of the leading coronavirus vaccines on the market. However

Better Stock Buy: AT&T vs. C3.ai: https://g.foolcdn.com/editorial/images/752007/young-trader-at-home.jpg
Better Stock Buy: AT&T vs. C3.ai

AT&T (NYSE: T) and C3.ai (NYSE: AI) generally appeal to different types of tech investors. AT&T, one of the largest telecom companies in America, is usually owned for stability and dividends instead

3 Dental Supply Stocks You Can Sink Your Teeth Into: https://g.foolcdn.com/editorial/images/751961/sitting-at-dental-chair-dentist-patient.jpg
3 Dental Supply Stocks You Can Sink Your Teeth Into

Like regular flossing, dental supply companies are sometimes overlooked, but Henry Schein (NASDAQ: HSIC), Dentsply Sirona (NASDAQ: XRAY), and Patterson Companies (NASDAQ: PDCO) are all thriving

EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Novartis Ag (NYSE: NVS)Q3 2023 Earnings CallOct 24, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

Why LianBio Stock Is Skyrocketing Today: https://g.foolcdn.com/editorial/images/752037/scientists-asian.jpg
Why LianBio Stock Is Skyrocketing Today

Shares of LianBio (NASDAQ: LIAN) were skyrocketing 132.4% higher as of 11:11 a.m. ET on Tuesday. The huge gain came after the company announced that it entered into an agreement to hand over

Centene (CNC) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Centene (CNC) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Centene (NYSE: CNC)Q3 2023 Earnings CallOct 24, 2023, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.: https://g.foolcdn.com/editorial/images/751839/a-doctor-looking-at-a-tablet-with-another-person.jpg
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.

Abbott Laboratories (NYSE: ABT) has been a disappointing investment in recent years. While COVID-19 testing gave the business a boost, this has largely been a slow-growing company. And since 2020

2 Beaten-Down Stocks That Haven't Been This Cheap in Over 6 Years: https://g.foolcdn.com/editorial/images/751834/a-couple-of-investors-looking-at-a-series-of-charts.jpg
2 Beaten-Down Stocks That Haven't Been This Cheap in Over 6 Years

Many growth stocks have come under pressure this year due to worsening macroeconomic conditions. Investors are concerned about inflation and a slowdown in the economy. Two stocks that have been

The Best Stocks to Invest $5,000 In Right Now: https://g.foolcdn.com/editorial/images/751878/gettyimages-103919680.jpg
The Best Stocks to Invest $5,000 In Right Now

Bear markets and bull markets come and go, so it's best to avoid building your portfolio around one specific market phase. Instead, pick up shares of companies with potential to grow your wealth

2 High-Yield Dividend Stocks to Buy Now and Hold for a Decade or Longer: https://g.foolcdn.com/editorial/images/751708/stock-market-trader-at-home-getty.jpg
2 High-Yield Dividend Stocks to Buy Now and Hold for a Decade or Longer

These days, finding dividend payers that offer eye-popping yields is as easy as clicking the sort button on your favorite stock screener. Unfortunately, the vast majority of stocks that float to the

Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today: https://g.foolcdn.com/editorial/images/751969/person-in-a-lab-looking-through-a-microscope.jpg
Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today

Hardly for the first time this year, biotech CymaBay Therapeutics (NASDAQ: CBAY) had a winning day on the market Monday. Following the news that its leading drug candidate had been granted an

Why Revolution Medicines Stock Is Crashing Today: https://g.foolcdn.com/editorial/images/751899/scientist-with-head-down.jpg
Why Revolution Medicines Stock Is Crashing Today

Shares of Revolution Medicines (NASDAQ: RVMD) were crashing 42.5% lower as of 11:13 a.m. ET on Monday. The steep decline came after the oncology company presented results on Sunday for RMC-6236 from

3 Stocks Cathie Wood Is Buying That Should Be on Your List Too: https://g.foolcdn.com/editorial/images/751770/dna-genetic-sequencing-biotech-1.jpg
3 Stocks Cathie Wood Is Buying That Should Be on Your List Too

Cathie Woods, through her various ARK funds, has been scooping up shares of Intellia Therapeutics (NASDAQ: NTLA), Block (NYSE: SQ), and Ginkgo Bioworks (NYSE: DNA) lately. All three stocks have

AT&T Just Raised Its Free-Cash-Flow Guidance. Here's Why It Should Still Suspend Its Dividend.: https://g.foolcdn.com/editorial/images/751648/person-makes-phone-call-while-looking-at-information-on-a-tablet.jpg
AT&T Just Raised Its Free-Cash-Flow Guidance. Here's Why It Should Still Suspend Its Dividend.

AT&T (NYSE: T) may finally have begun a long-awaited rebound. The stock surged 7% higher following its earnings announcement for the third quarter of 2023. A possible reason for the increase may

3 Unstoppable Stocks to Buy Sooner Rather Than Later: https://g.foolcdn.com/editorial/images/751591/scientists-happy.jpg
3 Unstoppable Stocks to Buy Sooner Rather Than Later

Some stocks have the "it" factor. They've got such tremendous growth prospects that investors want to add them to their portfolios without any hesitation.

Three Motley Fool investors think they've

Pfizer Just Announced Layoffs. Should You Still Buy the Stock?: https://g.foolcdn.com/editorial/images/751579/investor-considers-papers-at-a-cafe.jpg
Pfizer Just Announced Layoffs. Should You Still Buy the Stock?

On October 13, Pfizer (NYSE: PFE) served up a platter of bad news for investors. Aside from lowering its estimates for sales of its jab and its antiviral pill for COVID, the company reported that

3 Safe Dividend Stocks to Beat Inflation: https://g.foolcdn.com/editorial/images/751608/chain-and-padlock-wrapped-around-stack-of-100-dollar-bills-cash-money-locked-up.jpeg
3 Safe Dividend Stocks to Beat Inflation

Like it or not, inflation remains higher than Americans have been accustomed to, and the impacts of last year's price surge have not gone away. As of September, inflation as measured by the Consumer

If You Had Invested $10,000 in AT&T in 2013, This Is How Much You Would Have Today: https://g.foolcdn.com/editorial/images/749506/att-t-growth-stock-market-investment.jpg
If You Had Invested $10,000 in AT&T in 2013, This Is How Much You Would Have Today

AT&T (NYSE: T) has a history dating back to the late 1800s. And over many periods of that long and storied history, it's been a fantastic stock to own.

However, over the last 10 years, AT&T stock

Where Will AT&T Stock Be in 1 Year?: https://g.foolcdn.com/editorial/images/751680/att_retail_chicago.jpg
Where Will AT&T Stock Be in 1 Year?

AT&T's (NYSE: T) stock rallied nearly 7% on Oct. 19 after the telecom giant posted its third-quarter earnings report. Its revenue rose 1% year over year to $30.35 billion and surpassed analysts'

Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?: https://g.foolcdn.com/editorial/images/751646/jazz-pharma.jpg
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?

Pfizer (NYSE: PFE) and Roche (OTC: RHHBY) have disappointed investors this year. Pfizer's shares have dropped more than 39% this year, and it's trading near its 52-week low. Roche has seen its stock

Is Pfizer a Bad News Buy Right Now?: https://g.foolcdn.com/editorial/images/751705/gettyimages-1203044156.jpg
Is Pfizer a Bad News Buy Right Now?

Pfizer (NYSE: PFE) last year brought in record sales of more than $100 billion thanks to its dominance in the coronavirus prevention and treatment markets. The company sells the top vaccine

Why AT&T Stock Was Gaining Today: https://g.foolcdn.com/editorial/images/751737/5g-cellular-communications-tower.jpg
Why AT&T Stock Was Gaining Today

Shares of AT&T (NYSE: T) were gaining for the second day in a row today as a flurry of positive analyst notes gave the stock another boost. As of 1:37 p.m. ET, the stock was up 1.5% after gaining as

Why Knight-Swift Transportation Stock Popped Today: https://g.foolcdn.com/editorial/images/751717/truck-warehouse-loading-dock.jpg
Why Knight-Swift Transportation Stock Popped Today

Shares of Knight-Swift Transportation (NYSE: KNX) were moving higher today after the diversified transportation company topped analyst estimates in its third-quarter earnings report.

As of 11:27